Of note, the reduction in the survival rate was even more evident in CDK12-KI/PyMT vs. WT/PyMT male mice, likely due to the attenuation of the difference in female mice because of their very accelerated kinetics of tumor progression24. The gene discussed is CDK12; the disease is neoplasm.